| KARE-PHARMTECH-LLC |
KARE-PHARMTECH-LLC |
92%
|
the Company and PharmTech agreed to collaborate on an interim basis to commercialize certain PharmTech products through the distribution and pharmacy network of the Company |
| INDEPENDENT-RETAIL-PHARMACIES |
INDEPENDENT-RETAIL-PHARMACIES |
85%
|
Wellgistics LLC provides distribution and 3PL services to both pharmaceutical manufacturers and independent retail pharmacies. |
| COMMUNITY-SPECIALTY-PHARMACY-INC |
COMMUNITY-SPECIALTY-PHARMACY-INC |
80%
|
10.22 Participating Pharmacy Agreement dated February 6, 2023, by and between Medzoomer, Inc. and Community Specialty Pharmacy Inc. |
| MEDZOOMER-INC |
MEDZOOMER-INC |
80%
|
10.22 Participating Pharmacy Agreement dated February 6, 2023, by and between Medzoomer, Inc. and Community Specialty Pharmacy Inc. |
| DVLT |
Datavault AI Inc. |
72%
|
NOTE 6. INTANGIBLE ASSETS Intangible assets consist of the following: SCHEDULE OF INTANGIBLE ASSETS December 31, 2025 2024 Software development costs - Delivmeds $ 2,499,543 $ 1,618,017 Accumulated i… |
| DVLT |
Datavault AI Inc. |
72%
|
Reciprocal relationship from DVLT graph: Reciprocal relationship from WGRX graph: Reciprocal relationship from DVLT graph: Reciprocal relationship from WGRX graph: Reciprocal relationship from DVLT g… |
| SCNX |
Scienture Holdings, Inc. |
72%
|
tal inventory, at cost - Less: reserve for expired goods ( ) - Inventories, net $ $ - $ - Equipment - Furniture & Fixtures - Property, plant and equipment, gross - Less: Accumulated Depreciation ( ) … |
| SCNX |
Scienture Holdings, Inc. |
72%
|
Reciprocal relationship from SCNX graph: Reciprocal relationship from WGRX graph: tal inventory, at cost - Less: reserve for expired goods ( ) - Inventories, net $ $ - $ - Equipment - Furniture & Fix… |
| AGILE-CAPITAL-FUNDING-LLC |
AGILE-CAPITAL-FUNDING-LLC |
62%
|
on acceptable terms or at all. The following table summarizes our cash flows from operating, investing, and financing activities for the three months ended March 31, 2026 and 2025 : Three Months Ende… |
| ALLIANCE-PHARMA-SOLUTIONS-LLC |
ALLIANCE-PHARMA-SOLUTIONS-LLC |
62%
|
acy”), through an intermediary—Wood Sage, LLC. 27 Wellgistics, LLC Founded in 2013, Wellgistics, LLC serves as the wholesale arm of our healthcare ecosystem as a 50-state FDA licensed and NABP-accred… |
| AMERICAN-PHARMACEUTICAL-INGREDIENTS-LLC |
AMERICAN-PHARMACEUTICAL-INGREDIENTS-LLC |
62%
|
roximately $1,872,000, with fixed weekly payments over an estimated 33-week term. The August 2025 agreement was used to satisfy the outstanding balances of both the May 14, 2025 and June 25, 2025 arr… |
| ARVODA-CONSULTING-LLC |
ARVODA-CONSULTING-LLC |
62%
|
. The related unamortized debt discount was $ 711,547 , resulting in a net carrying amount of $ 1,653,853 , which is classified as a current liability in the condensed consolidated balance sheet. As … |
| AYAN-SPONSORS-LLC |
AYAN-SPONSORS-LLC |
62%
|
( 36,751 ) - Repayment of seller promissory note - ( 68,570 ) Proceeds from revolving line of credit - ( 310,561 ) Repayment of revolving line of credit ( 143,525 ) - Proceeds from convertible notes … |
| BLYTHE-GLOBAL-ADVISORS-LLC |
BLYTHE-GLOBAL-ADVISORS-LLC |
62%
|
nded March 31, 2026. As of December 31, 2025, the Company had an outstanding obligation of $ 225,000 due to its Chief Executive Officer, which was fully repaid during the three months ended March 31,… |
| CEDAR-ADVANCE-LLC |
CEDAR-ADVANCE-LLC |
62%
|
d $1,047,048 for the year ended December 31, 2024, related to the amortization of intangible assets identified and recorded in connection with those acquisitions. The remaining $158,804 and $67,616 f… |
| COMMUNITY-SPECIALTY-PHARMACY-LLC |
COMMUNITY-SPECIALTY-PHARMACY-LLC |
62%
|
nded March 31, 2026. As of December 31, 2025, the Company had an outstanding obligation of $ 225,000 due to its Chief Executive Officer, which was fully repaid during the three months ended March 31,… |
| DANAM-HEALTH-INC |
DANAM-HEALTH-INC |
62%
|
( 36,751 ) - Repayment of seller promissory note - ( 68,570 ) Proceeds from revolving line of credit - ( 310,561 ) Repayment of revolving line of credit ( 143,525 ) - Proceeds from convertible notes … |
| DEBT-INTEGRAL-HEALTH-INC |
DEBT-INTEGRAL-HEALTH-INC |
62%
|
d $1,047,048 for the year ended December 31, 2024, related to the amortization of intangible assets identified and recorded in connection with those acquisitions. The remaining $158,804 and $67,616 f… |
| DISTRIBUTION-WELLGISTICS-LLC |
DISTRIBUTION-WELLGISTICS-LLC |
62%
|
Company does have larger customers to whom they have extended terms for payment. Generally, payments from these customers are due within 30 days of their order being shipped. However, a few customers… |
| FIRST-DEFENSE-NASAL-SCREEN-CORP |
FIRST-DEFENSE-NASAL-SCREEN-CORP |
62%
|
fication of the liabilities that might be necessary should we be unable to continue as a going concern. NOTE 3. ACCOUNTS RECEIVABLE, NET Accounts receivable, net consist of the following: SCHEDULE OF… |
| HUB-LLC |
HUB-LLC |
62%
|
Other intangible assets, net $ 9,985,713 $ 10,314,675 16 Capitalized Software Software development costs relate to the Wellgistics Tech & Hub, LLC platform. As of March 31, 2026 and December 31, 2025… |
| INTEGRA-HEALTH-INC-BLUE-CAP-ACQUISITIONS-LLC |
INTEGRA-HEALTH-INC-BLUE-CAP-ACQUISITIONS-LLC |
62%
|
tain proprietary technology for use within the United States pharmaceutical distribution market. In connection with this agreement, the Company recorded a license right intangible asset of $ 2,500,00… |
| INTEGRAL-HEALTH-INC |
INTEGRAL-HEALTH-INC |
62%
|
tain proprietary technology for use within the United States pharmaceutical distribution market. In connection with this agreement, the Company recorded a license right intangible asset of $ 2,500,00… |
| INTEGRA-PHARMA-SOLUTIONS-LLC |
INTEGRA-PHARMA-SOLUTIONS-LLC |
62%
|
nded March 31, 2026. As of December 31, 2025, the Company had an outstanding obligation of $ 225,000 due to its Chief Executive Officer, which was fully repaid during the three months ended March 31,… |
| KARE-RX-HUB-LLC-KARE-PHARMTECH-LLC |
KARE-RX-HUB-LLC-KARE-PHARMTECH-LLC |
62%
|
All revenue for the Company is recognized at the point-in-time when delivered to customer based on contractual obligations. Any amount collected from customers for goods not yet delivered is recorded… |
| NOMAD-CAPITAL-LLC |
NOMAD-CAPITAL-LLC |
62%
|
nded March 31, 2026. As of December 31, 2025, the Company had an outstanding obligation of $ 225,000 due to its Chief Executive Officer, which was fully repaid during the three months ended March 31,… |
| RELATEDLY-WELLGISTICS-LLC-WOOD-SAGE-LLC |
RELATEDLY-WELLGISTICS-LLC-WOOD-SAGE-LLC |
62%
|
nded March 31, 2026. As of December 31, 2025, the Company had an outstanding obligation of $ 225,000 due to its Chief Executive Officer, which was fully repaid during the three months ended March 31,… |
| SILVERBACK-CAPITAL-CORPORATION |
SILVERBACK-CAPITAL-CORPORATION |
62%
|
nues to expand its commercial presence across its pharmacy and distribution segments. 31 Depreciation and Amortization Depreciation and amortization expense for the three months ended March 31, 2026 … |
| STRATEGIC-EP-LLC |
STRATEGIC-EP-LLC |
62%
|
roximately $1,872,000, with fixed weekly payments over an estimated 33-week term. The August 2025 agreement was used to satisfy the outstanding balances of both the May 14, 2025 and June 25, 2025 arr… |
| WELLGISTICS-LLC |
WELLGISTICS-LLC |
62%
|
nd adversely impact Wellgistics Health’s business operations, financial condition and results of operations. Wellgistics Pharmacy recognizes product revenue in accordance with ASC Topic 606, Revenue … |
